Fortaleza Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Fortaleza Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$149K	Sell	203 -92	-31%	-$106K	1.21%	30
2018 Q1	$470K	Sell	295 -142	-32%	-$183K	2.86%	1
2017 Q4	$392K	Sell	437 -246	-36%	-$146K	2.46%	1
2017 Q3	$246K	Hold	683	–	–	0.45%	65
2017 Q2	$200K	Buy	683 +136	+25%	+$39.3K	0.38%	81
2017 Q1	$192K	Hold	547	–	–	0.39%	80
2016 Q4	$101K	Hold	547	–	–	0.21%	125
2016 Q3	$141K	Buy	547 +7	+1%	+$1.8K	0.2%	95
2016 Q2	$115K	Buy	540 +140	+35%	+$31.3K	0.09%	111
2016 Q1	$82.6K	Hold	400	–	–	0.05%	130
2015 Q4	$101K	Buy	+400	New	+$82.3K	0.06%	127

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fortaleza Asset Management's NKTR Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Nektar Therapeutics (NKTR) stake by 31% in Q2 2018, selling an estimated $106K and leaving 203 shares worth $149K. The position accounts for 1.21% of the portfolio, ranked #30.

Fortaleza Asset Management first reported a position in NKTR in Q4 2015 and has held it in 11 quarters since. The position peaked at $470K in Q1 2018. 378 funds tracked by Wall St. Rank hold NKTR as of Q2 2018.

Fortaleza Asset Management held 203 shares of Nektar Therapeutics worth $149K as of Q2 2018.
Fortaleza Asset Management sold 92 Nektar Therapeutics shares in Q2 2018, an estimated $106K.
Nektar Therapeutics made up 1.21% of Fortaleza Asset Management's portfolio in Q2 2018, its #30 holding.
Fortaleza Asset Management first reported a position in Nektar Therapeutics in Q4 2015 and has held it in 11 quarters since.
Fortaleza Asset Management's Nektar Therapeutics position peaked at $470K in Q1 2018.
378 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.